Related Experiment Video
Updated: Apr 23, 2026

08:22
In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
Published on: October 27, 2020
2.6K
Therapeutic hypothermia after cardiac arrest
1Department of Intensive Care Medicine, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Annals of Cardiac Anaesthesia
|October 5, 2014
Summary
Therapeutic hypothermia improves outcomes for cardiac arrest survivors by mitigating brain damage. This treatment is now standard for selected comatose patients, balancing benefits and risks.
Area of Science:
- Neurology
- Critical Care Medicine
- Cardiology
Background:
- Prognosis after out-of-hospital cardiac arrest (OHCA) is often poor due to severe neuronal injury.
- Therapeutic hypothermia (TH) has emerged as a critical intervention for managing post-cardiac arrest neurological deficits.
- Clinical evidence supports TH's role in improving neurological function recovery in comatose survivors.
Purpose of the Study:
- To examine the multifaceted aspects of utilizing therapeutic hypothermia.
- To evaluate the application of TH in managing comatose patients post-cardiac arrest.
- To review the benefits and risks associated with TH in this patient population.
Main Methods:
- Review of clinical trials and guidelines on therapeutic hypothermia.
- Analysis of patient inclusion criteria for TH protocols.
- Examination of the impact of TH on neuronal function recovery.
Main Results:
- Induced hypothermia has demonstrated efficacy in facilitating neuronal function recovery.
- TH is incorporated into standard treatment protocols for selected cardiac arrest survivors.
- Careful patient selection minimizes hypothermia-associated complications while maximizing therapeutic benefits.
Conclusions:
- Therapeutic hypothermia is a valuable tool in the management of comatose patients following cardiac arrest.
- Optimized patient selection is crucial for successful TH implementation.
- Further examination of TH aspects supports its role in improving neurological outcomes.
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
1.6K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
Decreased Body Temperature
1.2K
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.2K
Methods of reducing fever
1.6K
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
1.6K

